Risk of venous thromboembolism in COVID‐19 infection

Risk of venous thromboembolism in COVID‐19 infection

The incidence of venous thromboembolism (VTE) for non‐hospitalised patients with coronavirus disease‐2019 infection has not been very widely studied. 13 019 persons with a positive SARS‐CoV‐2 nucleic acid amplification test were identified. In total, 447 (0.2%) VTEs were identified in the study popu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Internal medicine journal 2023-08, Vol.53 (8), p.1478-1480
Hauptverfasser: Honkanen, Meeri, Sirkeoja, Simo, Viskari, Hanna, Kailankangas, Ville, Sinisalo, Marjatta, Syrjänen, Jaana
Format: Artikel
Sprache:eng
Schlagworte:
Coronaviruses
COVID-19
epidemiology
outpatients
Population studies
pulmonary embolism
Pulmonary embolisms
Severe acute respiratory syndrome coronavirus 2
Thromboembolism
venous thromboembolism
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The incidence of venous thromboembolism (VTE) for non‐hospitalised patients with coronavirus disease‐2019 infection has not been very widely studied. 13 019 persons with a positive SARS‐CoV‐2 nucleic acid amplification test were identified. In total, 447 (0.2%) VTEs were identified in the study population, 293 (66%) of these were pulmonary embolisms. A positive SARS‐CoV‐2 test did not increase the risk for VTE in the univariate analysis (odds ratio (OR): 1.0, 95% confidence interval (CI): 0.69–1.4) or multivariable analysis (OR: 1.36, 95% CI: 0.93–1.97).
ISSN:1444-0903
1445-5994
DOI:10.1111/imj.16145